# Maraviroc 150 mg Leeds & Liverpool – HIV Treatment & Prescription Information | Vision Pharma
**Maraviroc 150 mg Leeds** and **Maraviroc 150 mg Liverpool** are location-focused search terms for people researching maraviroc tablets, HIV treatment information, prescription requirements and pharmaceutical support in the UK.
Maraviroc is a **CCR5 antagonist** used in combination with other antiretroviral medicines for treatment-experienced adults and adolescents weighing at least 30 kg who have detectable CCR5-tropic HIV-1. UK prescribing information states that treatment should be initiated by a physician experienced in managing HIV infection.
## Maraviroc 150 mg Leeds
People searching for **Maraviroc 150 mg Leeds**, **Maraviroc Leeds**, **Maraviroc tablets Leeds**, **Maraviroc prescription Leeds**, **Maraviroc HIV treatment Leeds**, or **Maraviroc medicine information Leeds** should obtain appropriate advice from a qualified healthcare professional.
Before treatment, an appropriately validated test should confirm that only CCR5-tropic HIV-1 is detectable. Maraviroc is not indicated when CXCR4-tropic or dual/mixed-tropic virus is detected.
The appropriate dose also depends on other medicines being taken. The current UK SmPC describes 150 mg, 300 mg or 600 mg twice-daily regimens depending on interactions with concomitant medicines, particularly potent CYP3A inhibitors or inducers.
## Maraviroc 150 mg Liverpool
For searches such as **Maraviroc 150 mg Liverpool**, **Maraviroc Liverpool**, **Maraviroc tablets Liverpool**, **Maraviroc prescription Liverpool**, and **Maraviroc HIV treatment Liverpool**, patients should consult an appropriate HIV specialist or healthcare service.
Liverpool has specialist HIV services, including the **Liverpool Tropical and Infectious Disease Unit** at Royal Liverpool University Hospital, which provides outpatient care for people living with HIV.
## Maraviroc 150 mg – Key Product Information
* **Active ingredient:** Maraviroc
* **Strength:** 150 mg
* **Medicine class:** CCR5 antagonist
* **Therapeutic area:** HIV-1 treatment
* **Dosage form:** Film-coated tablet
* **UK status:** Prescription-only medicine
* **Use:** Combination antiretroviral therapy
* **Patient selection:** CCR5-tropic HIV-1 must be confirmed through appropriate testing.
### Prescription & Safety Information
Maraviroc should be prescribed according to the patient's HIV status, treatment history, tropism test and other medicines. Drug interactions can change maraviroc exposure and may require dose adjustment.
Some UK prescribing formularies classify maraviroc as a restricted medicine requiring initiation by HIV consultants.
## International Pharmaceutical Support
**Vision Pharma** provides pharmaceutical product information and international sourcing support for customers and healthcare-related businesses across markets including the **United Kingdom, USA, UAE, Australia, Saudi Arabia, Germany, South Africa, France and Egypt**.
For searches covering **Leeds, Liverpool, London, Birmingham, Manchester, Cardiff, Bristol, Sheffield, Glasgow and Edinburgh**, Vision Pharma can provide product-related information subject to applicable prescription, importation, supply and regulatory requirements.
**Convenient payment options** may be available for eligible international pharmaceutical transactions, subject to applicable documentation and regulations.
**Maraviroc 150 mg Leeds; Maraviroc Leeds; Maraviroc tablets Leeds; Maraviroc prescription Leeds; Maraviroc HIV treatment Leeds; Maraviroc 150 mg Liverpool; Maraviroc Liverpool; Maraviroc tablets Liverpool; Maraviroc prescription Liverpool; Maraviroc HIV treatment Liverpool; Maraviroc 150 mg UK; Maraviroc medicine UK; Maraviroc prescription information UK; CCR5 antagonist Leeds; CCR5 antagonist Liverpool; HIV treatment information Leeds; HIV treatment information Liverpool; Celsentri 150 mg Leeds; Celsentri 150 mg Liverpool; maraviroc tablets UK; HIV medicine information Liverpool; HIV medicine information Leeds.**
## Frequently Asked Questions
### What is Maraviroc 150 mg used for?
Maraviroc is a CCR5 antagonist used together with other antiretroviral medicines for certain treatment-experienced patients with CCR5-tropic HIV-1.
### Is Maraviroc 150 mg prescription-only in the UK?
Yes. Current UK product information identifies Maraviroc 150 mg film-coated tablets as a **prescription-only medicine**.
### Is Maraviroc suitable for every person with HIV?
No. Its licensed use is specific to patients with detectable CCR5-tropic HIV-1, and appropriate tropism testing is required before treatment.
### Is 150 mg always the correct dose?
No. The prescribed dose can vary according to interactions with other medicines. The current UK SmPC describes 150 mg, 300 mg and 600 mg twice-daily regimens in different interaction settings. Patients should follow the regimen prescribed by their clinician.
